Comparison Beam Therapeutics (BEAM) with Competitors
Beam Therapeutics (BEAM) industry is Biotechnology.
Profit Margin
BEAM-40.20%
Industry-0.77%
Upside-39.43%
Operating Margin
BEAM-337.80%
Industry-2055.25%
Upside+1717.45%
Debt-to-Equity
BEAM8.60%
Industry28.27%
Upside-69.56%
Free Cash Flow Yield
BEAM-12.11%
Industry-1.75%
Upside-10.37%
P/E
BEAM-47.18
Industry-20.52
Upside-2666.50%
P/S
BEAM17.79
Industry10.01
Upside+77.66%
P/B
BEAM2.73
Industry5.15
Upside-47.05%